In the present this study, having excluded the presence of mutations in EGFR or KRAS by highly specific and sensitive techniques in the primary tumor, we are able to confirm that the mutations detected in other lung cells were not the result of contamination from the tumor. The gene discussed is KRAS; the disease is neoplasm.